T32.73
Corrosions involving 70-79% of body surface with 30-39% third degree corrosion
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code T32.73 refers to severe skin injuries caused by corrosive substances, affecting a significant portion of the body surface. Specifically, it describes cases where 70-79% of the body surface is involved, with 30-39% experiencing third-degree (full-thickness) burns or corrosion. This type of injury typically results from exposure to highly destructive chemical or thermal agents and requires comprehensive medical care due to its extensive and severe nature.
Causes & Symptoms
Clinical Causes: Accidental contact with strong acids or alkalis in industrial settings or laboratories Chemical spills or splashes involving corrosive agents Intentional exposure during acts of self-harm Thermal injuries from explosions or fires involving corrosive chemicals Negligence or accidents involving corrosive substances at workplaces or homes
Key Symptoms: Extensive skin redness and blistering Deep tissue damage visibly involving the skin layers Severe pain or, in some cases, a loss of sensation in affected areas Swelling and inflammation around the injured regions Presence of charred or blackened skin in third-degree burn areas Possible systemic symptoms such as fever, chills, or signs of infection
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a physical examination of the burned or corroded areas, assessing the extent and depth of tissue damage. Medical professionals may use the following methods:
Treatment Protocols: Managing extensive corrosive injuries involves urgent and multidisciplinary approaches, including:
Clinical Advice & FAQs
Billing Guidance
Is T32.73 a billable ICD-10 code?
Yes, T32.73 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T32.73?
Clinical documentation must specify the nature of Corrosions involving 70-79% of body surface with 30-39% third degree corrosion and any associated comorbidities for accurate reporting.
Cite this Clinical Reference